Michael Gelband’s Concentrix CNXC Stock Holding History

Michael Gelband’s Portfolio CNXC Stock Details CNXC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$583K	Buy	26,024 +11,848	+84%	+$309K	﹤0.01%	1198
2026 Q1	$388K	Buy	+14,176	New	+$503K	﹤0.01%	1255
2025 Q3	–	Sell	-10,311	Closed	-$545K	–	1602
2025 Q2	$545K	Buy	+10,311	New	+$545K	﹤0.01%	1130
2025 Q1	–	Sell	-45,508	Closed	-$1.97M	–	1537
2024 Q4	$1.97M	Buy	+45,508	New	+$2.02M	0.01%	714
2023 Q2	–	Sell	-24,754	Closed	-$3.01M	–	1900
2023 Q1	$3.01M	Buy	24,754 +19,499	+371%	+$2.65M	0.02%	718
2022 Q4	$700K	Sell	5,255 -14,431	-73%	-$1.75M	0.01%	1068
2022 Q3	$2.2M	Buy	+19,686	New	+$2.52M	0.03%	764
2022 Q2	–	Sell	-5,692	Closed	-$948K	–	2004
2022 Q1	$948K	Buy	+5,692	New	+$1.08M	0.01%	1194
2021 Q4	–	Sell	-1,383	Closed	-$245K	–	2214
2021 Q3	$245K	Sell	1,383 -10,562	-88%	-$1.75M	﹤0.01%	1704
2021 Q2	$1.92M	Buy	11,945 +10,168	+572%	+$1.56M	0.02%	702
2021 Q1	$266K	Buy	+1,777	New	+$215K	﹤0.01%	1736

Other funds holding CNXC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

KGI

Kopernik Global Investors Tampa, Florida $1.63B AUM 27.98% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

GBL

Groupe Bruxelles Lambert Brussels, Belgium $62.2M AUM 57.6% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

Michael Gelband's CNXC Position: Q2 2026 in Review

Michael Gelband increased its Concentrix (CNXC) stake by 84% in Q2 2026, buying an estimated $309K and bringing the position to 26,024 shares worth $583K. The position accounts for ﹤0.01% of the portfolio, ranked #1198.

Michael Gelband first reported a position in CNXC in Q1 2021 and has held it in 11 quarters since. The position peaked at $3.01M in Q1 2023. 269 funds tracked by Wall St. Rank hold CNXC as of Q2 2026.

Michael Gelband held 26,024 shares of Concentrix worth $583K as of Q2 2026.
Michael Gelband bought 11,848 Concentrix shares in Q2 2026, an estimated $309K.
Concentrix made up ﹤0.01% of Michael Gelband's portfolio in Q2 2026, its #1198 holding.
Michael Gelband first reported a position in Concentrix in Q1 2021 and has held it in 11 quarters since.
Michael Gelband's Concentrix position peaked at $3.01M in Q1 2023.
269 funds tracked by Wall St. Rank held Concentrix as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.